Dalrada Financial Corporation announced on May 21 that its wholly-owned healthcare subsidiary, Genefic, Inc., has acquired IV Services, LLC for an undisclosed price.
IV Services is a pharmaceutical business and infusion management leader with full pharmacy licenses in Louisiana and Mississippi.
Genefic delivers modern systems and specialty pharmacy solutions for better care and a better patient experience. Genefic’s pharmacy solution, Genefic Specialty Pharmacy, offers more than 30 years of dedicated expertise in providing patient advocacy through end-to-end prescription services, medical education and patient advocacy and support.
The acquisition of IV Services expands Genefic’s existing pharmacy sales and operational footprint. Furthermore, the acquisition will also increase Genefic’s top-line revenue through new product offerings with its established patient base and payor contracts with major insurance carriers, which strengthens its current specialty pharmacy business. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this acquisition marks the sixth infusion services transaction of 2024. There were eight deals announced in the infusion services specialty during 2023, and 32 announced in the specialty during 2022.
